TY - JOUR
T1 - Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi
AU - Dever, L. L.
AU - Jorgensen, J. H.
AU - Barbour, A. G.
PY - 1993
Y1 - 1993
N2 - The in vitro activities of the macrolide antibiotics clarithromycin, 14- hydroxy-clarithromycin, azithromycin, and erythromycin against 19 isolates of Borrelia burgdorferi were investigated. MICs ranged from 0.003 to 0.03 μg of clarithromycin per ml, 0.007 to 0.03 μg of 14-hydroxyclarithromycin per ml, 0.003 to 0.03 μg of azithromycin per ml, and 0.007 to 0.06 μg of erythromycin per ml. Time-kill studies using the B31 strain of B. burgdorferi demonstrated a ≥3-log10-unit killing after 72 h with each of the macrolide antibiotics tested in concentrations representing twice the respective MICs.
AB - The in vitro activities of the macrolide antibiotics clarithromycin, 14- hydroxy-clarithromycin, azithromycin, and erythromycin against 19 isolates of Borrelia burgdorferi were investigated. MICs ranged from 0.003 to 0.03 μg of clarithromycin per ml, 0.007 to 0.03 μg of 14-hydroxyclarithromycin per ml, 0.003 to 0.03 μg of azithromycin per ml, and 0.007 to 0.06 μg of erythromycin per ml. Time-kill studies using the B31 strain of B. burgdorferi demonstrated a ≥3-log10-unit killing after 72 h with each of the macrolide antibiotics tested in concentrations representing twice the respective MICs.
UR - http://www.scopus.com/inward/record.url?scp=0027236465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027236465&partnerID=8YFLogxK
U2 - 10.1128/AAC.37.8.1704
DO - 10.1128/AAC.37.8.1704
M3 - Comment/debate
C2 - 8215288
AN - SCOPUS:0027236465
SN - 0066-4804
VL - 37
SP - 1704
EP - 1706
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 8
ER -